Astonea Labs Ltd Intrinsic Value
ASTONEALAB · Healthcare · Current price ₹268
Is Astonea Labs Ltd undervalued?
DocStoX estimates the fair value of Astonea Labs Ltd at ₹87 per share, versus the current market price of ₹268. That puts the stock about -67.4% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹51), Relative P/E (₹168), Graham floor (₹73). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹51 (bear) to ₹87 (base) to ₹168 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹268 versus an intrinsic value of ₹87, Astonea Labs Ltd currently offers -67.4% of negative margin (i.e. a premium).
More on Astonea Labs Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.